A Vaxinano's project awards by the european commission
Monday, December 04th 2017
The TOXOFREE project receives the Seal of Excellence by the european commission managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020.
The TOXOFREE project (Production transfer to GMP standards of nanoparticle based
vaccine for regulatory preclinical and toxicity studies) Submitted under the Horizon 2020’s SME instrument phase 2 obtained the european Seal of Excellence
In the EU Framework Programme for Research and Innovation 2014-2020, this seal awards the stringent Horizon 2020 assessment thresholds for the 3 award criteria
(excellence, impact, quality and efficiency of implementation) and should facilitate the access to various european, national or regional grants.
